Ilene C. Wetiz, MD, professor of clinical medicine at the Keck School of Medicine at the University of Southern California, discusses the treatment options for this case: So, what are the ...

discusses the selected treatment and the results of the case: So, what happened to this patient? Well, we started her on a C5 inhibitor because she had a very large PNH clone. You can see on the ...

Bkemv is being offered at 10% off Soliris, and Epysqli is offered at 30% below Soliris. Both biosimilars treat several of the ...

"But the point is that we have multiple options that we can offer patients who continue to have anemia despite treatment with C5 inhibitors." Shammo also encouraged patients with PNH to seek out ...

Along with haemolysis, people with PNH can suffer life-threatening blood ... so there's a clear need for new treatment options, according to Prof Jun Ho Jang of Sungkyunkwan University in South ...

With the expansion of oral treatment options, adherence is also becoming a stronger driver in prescribing decisions. The competitive landscape for PNH has seen significant shifts, particularly ...